株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

OTC医薬品の世界市場の将来予測 (2017〜2027年):咳・風邪・アレルギー薬、鎮痛剤、胃腸薬、皮膚薬、アイケア用品、禁煙補助製品など

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

発行 Visiongain Ltd 商品コード 320889
出版日 ページ情報 英文 177 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=153.22円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[?]アイコンをクリックしてご確認ください。

Back to Top
OTC医薬品の世界市場の将来予測 (2017〜2027年):咳・風邪・アレルギー薬、鎮痛剤、胃腸薬、皮膚薬、アイケア用品、禁煙補助製品など Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others
出版日: 2017年08月15日 ページ情報: 英文 177 Pages
概要

世界のOTC医薬品 (一般用医薬品) 市場は、2016年に1270億米ドルの規模に達し、そして今後も6.5%のCAGR (複合年間成長率) で成長し続ける、と予測されています。市場の23%を、咳・風邪・アレルギー用医薬品が占めています。

当レポートでは、世界のOTC医薬品 (一般用) 市場について分析し、製品・市場の概要や最新動向、市場規模の動向見通し (今後11年間分)、製品別・地域別の詳細動向、市場の質的傾向 (促進・抑制要因、市場求心力など)、主要企業のプロファイル、今後の市場成長の可能性などをまとめています。

第1章 分析概要

第2章 OTC医薬品の概略

  • OTC医薬品とは?
  • OTC医薬品の分類
  • OTC医薬品の要件
  • OTCスイッチ:処方薬からOTCへの切り替える方法は?
  • OTC医薬品の製造と流通
  • OTC医薬品に関する各国の法規制

第3章 世界のOTC医薬品市場の予測 (今後11年間分)

  • OTC医薬品市場の現状

第4章 世界のOTC医薬品市場:製品別の予測 (今後11年間分)

  • 概要
  • 咳、風邪、アレルギー
    • 抗アレルギー製品
  • 鎮痛剤 (内服薬、外用薬)
  • 胃腸薬
  • 皮膚薬
    • 切り傷、外傷
    • にきび
    • 発疹、かゆみ、皮膚炎/湿疹
    • いぼ
    • 皮膚真菌感染症
    • 痔核
    • その他
  • アイケア用品
    • ドライアイ症候群
    • 細菌性結膜炎
    • 眼アレルギー/アレルギー性結膜炎
    • 眼アレルギー/アレルギー性結膜炎の治療薬
  • 禁煙補助製品
  • その他

第5章 世界のOTC医薬品市場:地域別・国別の予測 (今後11年間分)

  • 地域別の市場予測 (今後11年間分)
  • 北米市場 (米国、カナダ、メキシコ)
  • 南米市場 (ブラジル、アルゼンチン、パラグアイ、ボリビアなど)
  • 欧州市場 (フランス、ドイツ、英国、スペイン、イタリアなど)
  • アジア太平洋地域市場 (日本、インド、オーストラリア、タイなど)
  • 他の国々の市場 (RoW:中東、アフリカなど)

第6章 OTC医薬品市場の質的分析

  • OTC医薬品市場のSWOT分析
  • 強み
    • 全てのステークホルダーが、OTC医薬品への移行でメリットを得る
      • 医薬品メーカー:OTC医薬品の売上利益の獲得
      • 保険金支払者:コスト負担の削減
      • 医療事業者:患者へのコスト転嫁
    • 多くの製薬企業が、OTC医薬品の幅広いポートフォリオを抱えている
    • 規制当局によるOTC医薬品の推奨
    • 小売薬局・代替的流通手段の発達による、効率的な流通ネットワーク
    • 偽造医薬品の消費抑制
    • 文化的変化・OTC医薬品を用いた自己治療
  • 弱み
    • 製薬企業:処方薬への注力の継続
    • 製造上の問題:OTC医薬品の売上高・評判にも影響
    • 政府の価格規制の影響を受けやすいOTC製品
    • OTC医薬品へのコスト引き下げ圧力
  • 機会
    • 人口・経済構造の変化による、成長機会の創出
    • OTCスイッチの新たなカテゴリー
    • 新興国市場の急速な成長
    • 新たな医療技術による、OTC医薬品の認証の可能性
    • ソーシャルメディア/オンラインマーケティングでの販売促進機会
    • 自己治療による疾患未治療率引き下げの可能性
  • 脅威
    • プライベートブランドとの競合による収益率の引き下げ
    • 安全・誤用に対する規制面での不安感が、製品の撤退を促す
    • 特定の国々・集団におけるOTCスイッチへの抵抗感
  • ポーターのファイブフォース分析
    • 企業間競争の激しさ (高)
    • 新規参入企業の脅威 (中)
    • サプライヤーの交渉力 (低)
    • バイヤーの交渉力 (中)
    • 代替製品の脅威 (中)

第7章 OTC医薬品市場の代表的企業

  • Bayer AG
    • 企業概要
    • 製品ポートフォリオ
    • 近年の動向
  • GlaxoSmithKline PLC (GSK Consumer Care)
  • Johnson & Johnson
  • Perrigo Company PLC
  • 第一三共
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A.
  • Reckitt Benckiser Group PLC
  • Cipla Inc.

第8章 結論

  • 世界のOTC医薬品市場の将来展望
    • OTC医薬品の有力カテゴリー
    • 主要国市場:新興国が大半のシェアを占める
    • 世界のOTC医薬品市場の成長率
    • 今後のOTCスイッチの可能性
    • 潜在的なOTC市場
  • 分析結論

付録

図表一覧

分析対象企業・機関一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHA0224

The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceutical market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 177-page report you will receive 82 tables and 79 figures - all unavailable elsewhere.

The 177-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global OTC Pharmaceutical Market forecasts from 2017-2027
  • This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
  • Analgesics
  • Cough, cold and allergy products
  • Dermatological products
  • Gastrointestinal products
  • Eye Care
  • Smoking Cessation Aids
  • Other products

Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW

  • This report provides individual revenue forecasts to 2027 for these regional and national markets:
  • North America: the US, Canada, Mexico
  • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
  • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
  • Rest of the World: Middle East, Africa, Other Countries

image1

  • Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market
  • This report discusses the leading companies in the Global OTC Pharmaceutical market
  • Bayer AG
  • GlaxoSmithKline (GSK) Consumer Care
  • Perrigo Company PLC
  • Johnson & Johnson
  • Daiichi Sankyo Co., Ltd
  • Pfizer Inc.
  • Procter & Gamble
  • Sanofi S.A
  • Reckitt Benckiser Group PLC
  • Cipla, Inc.

Visiongain's study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 The OTC Pharmaceuticals Market Overview
  • 1.2 Research Methodology
  • 1.3 Global OTC Pharmaceutical Market Segmentation
  • 1.4 Why You Should Read This Report
  • 1.5 How this report delivers?
  • 1.6 Key Questions Answered by This Analytical Report
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Who is This Report For?
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals

  • 2.1 What Are OTC Pharmaceuticals?
  • 2.2 Classification of OTC Pharmaceuticals
  • 2.3 What are the Requirements for an OTC Pharmaceutical Drug?
  • 2.4 OTC Switching
    • 2.4.1 How Is a Drug Switched from Prescription to OTC?
  • 2.5 Manufacturing and Distribution of OTC Pharmaceuticals
  • 2.6 Regulation of OTC Pharmaceuticals
    • 2.6.1 Regulation of OTC Pharmaceuticals in the US
    • 2.6.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
    • 2.6.3 Regulation of OTC Pharmaceuticals in Europe
    • 2.6.4 Regulation of OTC Pharmaceuticals in China
    • 2.6.5 Regulation of OTC Pharmaceuticals in Others Countries

3. Global OTC Pharmaceutical Market Forecast 2017-2027

  • 3.1 The Current State of the OTC Pharmaceutical Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2017- 2027

  • 4.1 Overview
  • 4.2 Cough, Cold and Allergy
    • 4.2.1 Anti-Allergy Products
  • 4.3 Analgesics
    • 4.3.1 Internal Analgesics
    • 4.3.2 External Analgesics
  • 4.4 Gastrointestinal
  • 4.5 Dermatological
    • 4.5.1 Minor Cuts and Wounds
    • 4.5.2 Acne
    • 4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema
    • 4.5.4 Cold Sores
    • 4.5.5 Warts
    • 4.5.6 Fungal Skin Infections
    • 4.5.7 Haemorrhoids
    • 4.5.8 Other Dermatological Products
  • 4.6 Eye Care
    • 4.6.1 Dry Eye Syndrome
    • 4.6.2 Bacterial Conjunctivitis
    • 4.6.3 Ocular Allergy and Allergic Conjunctivitis
    • 4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
  • 4.7 Smoking Cessation Aids
  • 4.8 Other Products

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2017- 2027

  • 5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2017-2027
  • 5.2 North American OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.1 USA OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.2 Canada OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.2.3 Mexico OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.3 South American OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.1 Brazil OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.2 Argentina OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.3 Paraguay OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.4 Bolivia OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.3.5 Rest of South America OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.4 European OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.1 France OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.2 Germany OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.3 UK OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.4 Spain OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.5 Italy OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.4.6 Rest of Europe OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.5 Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.1 China OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.2 Japan OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.3 India OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.4 Australia OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.5 Thailand OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.5.6 Rest of Asia-Pacific OTC Pharmaceutical Market Forecasts 2017-2027
  • 5.6 Rest of World OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.1 Middle East OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.2 Africa OTC Pharmaceutical Market Forecasts 2017-2027
    • 5.6.3 Other Countries OTC Pharmaceutical Market Forecasts 2017-2027

6. Qualitative Analysis of the OTC Pharmaceutical Market, 2017-2027

  • 6.1 SWOT Analysis of the OTC Pharmaceutical Market
  • 6.2 Strengths
    • 6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
      • 6.2.1.1 Manufacturers Can Reap OTC Sales Benefits
      • 6.2.1.2 Third Party Payers: Reducing the Cost Burden
      • 6.2.1.3 Healthcare Systems: Pushing the Cost to the Consumer
    • 6.2.2 Many Pharmaceutical Companies Have a Strong Potential OTC Portfolio
    • 6.2.3 Regulators Are Encouraging OTC Approvals
    • 6.2.4 Effective Distribution Networks Due to Expansion of Retail Pharmacy and Alternative Distributors
    • 6.2.5 Deterring the Consumption of Counterfeit Drugs
    • 6.2.6 Cultural Changes Will Support Self-Medication with OTC Medicines
  • 6.3 Weaknesses
    • 6.3.1 Pharma Companies Remain Focused on Prescription Drugs
    • 6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
    • 6.3.3 OTC Products are Vulnerable to Price Controls by Governments
    • 6.3.4 Downward Cost Pressures of OTC Drugs
  • 6.4 Opportunities
    • 6.4.1 Demographic and Economic Changes Will Create Growth Opportunities
    • 6.4.2 New OTC Switch Categories
    • 6.4.3 Strong Growth in Emerging Markets
    • 6.4.4 New Healthcare Technologies May enable OTC Approvals
    • 6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
    • 6.4.6 Self-Medication Can Reduce the Under Treatment of Disease
  • 6.5 Threats
    • 6.5.1 Competition from Private-Label Brands Will Reduce Profitability
    • 6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
    • 6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
  • 6.6 Porter's Five Forces Analysis of the OTC Pharmaceutical Market
    • 6.6.1 Rivalry Among Competitors [High]
    • 6.6.2 Threat of New Entrants [Medium]
    • 6.6.3 Power of Suppliers [Low]
    • 6.6.4 Power of Buyers [Medium]
    • 6.6.5 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceutical Market

  • 7.1 Bayer AG
    • 7.1.1 Bayer AG: Company Overview
    • 7.1.2 Bayer AG: Product Portfolio
    • 7.1.3 Bayer AG: Recent Developments
  • 7.2 GlaxoSmithKline PLC (GSK Consumer Care)
    • 7.2.1 GlaxoSmithKline PLC: Company Overview
    • 7.2.2 GlaxoSmithKline PLC: Product Portfolio
    • 7.2.3 GlaxoSmithKline PLC: Recent Developments
  • 7.3 Johnson & Johnson
    • 7.3.1 Johnson & Johnson: Company Overview
    • 7.3.2 Johnson & Johnson: Product Portfolio
    • 7.3.3 Johnson & Johnson: Recent Developments
  • 7.4 Perrigo Company PLC
    • 7.4.1 Perrigo Company PLC: Company Overview
    • 7.4.2 Perrigo Company PLC: Product Portfolio
    • 7.4.3 Perrigo Company PLC: Recent Developments
  • 7.5 Daiichi Sankyo Co., Ltd.
    • 7.5.1 Daiichi Sankyo Co., Ltd.: Company Overview
    • 7.5.2 Daiichi Sankyo Co., Ltd.: Recent Developments
  • 7.6 Pfizer Inc.
    • 7.6.1 Pfizer Inc.: Company Overview
    • 7.6.2 Pfizer Inc.: Product Portfolio
    • 7.6.3 Pfizer Inc.: Recent Developments
  • 7.7 Procter & Gamble
    • 7.7.1 Procter & Gamble: Company Overview
    • 7.7.2 Procter & Gamble: Product Portfolio
    • 7.7.3 Procter & Gamble: Recent Developments
  • 7.8 Sanofi S.A.
    • 7.8.1 Sanofi S.A.: Company Overview
    • 7.8.2 Sanofi S.A.: Product Portfolio
    • 7.8.3 Sanofi S.A: Recent Developments
  • 7.9 Reckitt Benckiser Group PLC
    • 7.9.1 Reckitt Benckiser Group PLC: Company Overview
    • 7.9.2 Reckitt Benckiser Group PLC: Product Portfolio
    • 7.9.3 Reckitt Benckiser Group PLC: Recent Developments
  • 7.10 Cipla Inc.
    • 7.10.1 Cipla Inc.: Company Overview
    • 7.10.2 Cipla Inc.: Product Portfolio
    • 7.10.3 Cipla Inc.: Recent Developments

8. Conclusions

  • 8.1 The World OTC Pharmaceutical Market in 2016-2017
    • 8.1.1 The Leading OTC Product Categories
    • 8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion
    • 8.1.3 The Global OTC Market Growth Factors
    • 8.1.4 Potential OTC Switching, 2017-2027
    • 8.1.5 Emerging OTC Markets
  • 8.2 Concluding Remarks

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.1 Global OTC Pharmaceutical Market Forecast, by Product ($bn, AGR%) 2017-2027
  • Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2017
  • Table 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.4 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn, AGR%) 2017-2027
  • Table 4.5 OTC Internal Analgesic Active Ingredients, 2017
  • Table 4.6 OTC External Analgesic Active Ingredients, 2017
  • Table 4.7 Global OTC Pharmaceutical Market for Analgesics Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.8 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.9 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.10 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.11 OTC Antifungal Active Ingredients, 2017
  • Table 4.12 Global OTC Pharmaceutical Market for Dermatological Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.13 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn, AGR%) 2017-2027
  • Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2017
  • Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2017
  • Table 4.16 OTC Ocular Allergy Active Ingredients, 2017
  • Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.18 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2017
  • Table 4.20 Global OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.21 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 4.22 Global OTC Pharmaceutical Market for Other Products Market Forecast, ($bn, AGR%) 2017-2027
  • Table 4.23 OTC Pharmaceutical Market for Other Products Market Forecast,by Geography ($bn, AGR%) 2017-2027
  • Table 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn, AGR%) 2017-2027
  • Table 5.2 North America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.3 USA OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.6 South America OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.7 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.8 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.9 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.10 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.11 Rest of South America OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.12 European OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.13 France OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.14 Germany OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.15 UK OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.16 Spain OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.17 Italy OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.18 Rest of European OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.19 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.20 China OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.21 Selected Leading Companies in the Japanese OTC Pharma Market, 2017
  • Table 5.22 Japan OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.23 India OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.24 Australia OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.25 Thailand OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.26 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.27 Rest of World OTC Pharmaceutical Market Forecast, by Country ($bn, AGR%) 2017-2027
  • Table 5.28 Middle East OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.29 Africa OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 5.30 Other Countries OTC Pharmaceutical Market Forecast, ($bn, AGR%) 2017-2027
  • Table 7.1 Bayer AG: Company Overview
  • Table 7.2 Bayer AG: Product Portfolio
  • Table 7.4 GlaxoSmithKline PLC: Company Overview
  • Table 7.5 GlaxoSmithKline PLC: Product Portfolio
  • Table 7.6 GlaxoSmithKline PLC: Recent Developments
  • Table 7.7 Johnson & Johnson: Company Overview
  • Table 7.8 Johnson & Johnson: Product Portfolio
  • Table 7.9 Johnson & Johnson: Recent Developments
  • Table 7.10 Perrigo Company PLC: Company Overview
  • Table 7.11 Perrigo Company PLC: Product Portfolio
  • Table 7.12 Perrigo Company PLC: Recent Developments
  • Table7.13 Daiichi Sankyo Co., Ltd.: Company Overview
  • Table 7.14 Daiichi Sankyo Co., Ltd.: Recent Developments
  • Table 7.15 Pfizer Inc.: Company Overview
  • Table 7.16 Pfizer Inc.: Product Portfolio
  • Table 7.17 Pfizer Inc.: Recent Developments
  • Table 7.18 Procter & Gamble: Company Overview
  • Table 7.19 Procter & Gamble: Product Portfolio
  • Table 7.20 Procter & Gamble: Recent Developments
  • Table 7.21 Sanofi S.A.: Company Overview
  • Table 7.22 Sanofi S.A.: Product Portfolio
  • Table 7.23 Sanofi S.A: Recent Developments
  • Table 7.24 Reckitt Benckiser Group PLC: Company Overview
  • Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio
  • Table 7.26 Reckitt Benckiser Group PLC: Recent Developments
  • Table 7.27 Cipla Inc.: Company Overview
  • Table 7.28 Cipla Inc.: Product Portfolio
  • Table 7.29 Cipla Inc.: Recent Developments

List of Figures

  • Figure 1.1 OTC Pharmaceuticals: Overview of Submarkets
  • Figure 2.1 The OTC Pharmaceutical Supply Chain, 2017
  • Figure 3.1 OTC Pharmaceutical Market, by Product, ($bn), 2017-2027
  • Figure 3.2 OTC Pharmaceutical Market, by Geography, ($bn), 2017-2027
  • Figure 4.1 OTC Pharmaceutical Market, by Product, Market Share (%), 2016
  • Figure 4.2 OTC Pharmaceutical Market, by Product, Forecast ($bn) 2017-2027
  • Figure 4.3 OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.4 OTC Pharmaceutical Market for Analgesics Market Forecast, by Geography ($bn) 2017-2027
  • Figure 4.5 OTC Pharmaceutical Market for Gastrointestinal Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.6 OTC Pharmaceutical Market for Dermatological Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.7 OTC Pharmaceutical Market for Eye Care Market Forecast, by Geography($bn) 2017-2027
  • Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.9 OTC Pharmaceutical Market for Other Products Market Forecast, by Geography($bn) 2017-2027
  • Figure 5.1 OTC Pharmaceutical Market Forecast, by Geography ($bn) 2017-2027
  • Figure 5.2 Global OTC Pharmaceutical Market, by Geography, Market Share (%), 2016
  • Figure 5.3 North America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.4 North America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.5 USA OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.6 Canada OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.7 Mexico OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.8 South America OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.9 South America OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.10 Brazil OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.11 Argentina OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.12 Paraguay OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.13 Bolivia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.14 Rest of South America OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.15 Europe OTC Pharmaceutical Market Forecast, by Country($bn) 2017-2027
  • Figure 5.16 Europe OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.17 France OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.18 Germany OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.19 UK OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.20 Spain OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.21 Italy OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.22 Rest of Europe OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.23 Asia-Pacific OTC Pharmaceutical Market Forecast, by Country ($billion) 2017-2027
  • Figure 5.24 Asia-Pacific OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.25 China OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.26 Japan OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.27 India OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.28 Australia OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.29 Thailand OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.30 Rest of Asia-Pacific OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.31 RoW OTC Pharmaceutical Market Forecast, by Country ($bn) 2017-2027
  • Figure 5.32 Rest of World OTC Pharmaceutical Market, by Country, Market Share (%), 2016
  • Figure 5.33 Middle East OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.34 Africa OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 5.35 Other Countries OTC Pharmaceutical Market Forecast ($bn) 2017-2027
  • Figure 6.1 Porter's Five Analysis of the OTC Pharmaceutical Market, 2017
  • Figure 7.1 Bayer AG, Revenue, ($million), 2012-2016
  • Figure 7.2 Bayer AG, Product Segments Share (%), 2016
  • Figure 7.3 Bayer AG, Geographic Presence Share (%), 2016
  • Figure 7.4 GlaxoSmithKline PLC, Revenue, ($million), 2012-2016
  • Figure 7.5 GlaxoSmithKline PLC, Product Segments Share (%), 2016
  • Figure 7.6 GlaxoSmithKline PLC, Geographical Presence Share (%), 2016
  • Figure 7.7 Johnson & Johnson, Revenue, ($million), 2012-2016
  • Figure 7.8 Johnson & Johnson, Product Segments Share (%), 2016
  • Figure 7.9 Johnson & Johnson, Geographical Presence Share (%), 2016
  • Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2012-2016
  • Figure 7.11 Perrigo Company PLC, Product Segments Share (%), 2016
  • Figure 7.12 Perrigo Company PLC, Geographical Presence Share (%), 2016
  • Figure 7.13 Daiichi Sankyo Co., Ltd., Revenue, ($million), 2012-2016
  • Figure 7.14 Daiichi Sankyo Co., Ltd., Product Segments Share (%), 2016
  • Figure 7.15 Daiichi Sankyo Co., Ltd., Geographical Presence Share (%), 2016
  • Figure 7.16 Pfizer Inc., Revenue, ($million), 2012-2016
  • Figure 7.17 Pfizer Inc., Product Segments Share (%), 2016
  • Figure 7.18 Pfizer Inc., Geographical Presence Share (%), 2016
  • Figure 7.19 Procter & Gamble, Revenue, ($million), 2012-2016
  • Figure 7.20 Procter & Gamble, Product Segments Share (%), 2016
  • Figure 7.21 Procter & Gamble, Geographical Presence Share (%), 2016
  • Figure 7.22 Sanofi S.A., Revenue, ($million), 2012-2016
  • Figure 7.23 Sanofi S.A., Product Segments Share (%), 2016
  • Figure 7.24 Sanofi S.A., Geographical Presence Share (%), 2016
  • Figure 7.25 Reckitt Benckiser Group PLC, Revenue, ($million), 2012-2016
  • Figure 7.26 Reckitt Benckiser Group PLC, Product Segments Share (%), 2016
  • Figure 7.27 Cipla Inc., Revenue, ($million), 2012-2016
  • Figure 7.28 Cipla Inc., Product Segments Share (%), 2016
  • Figure 8.1 Global OTC Pharmaceutical Market Revenue, by Product Type ($bn), 2017-2027
  • Figure 8.2 Global OTC Pharmaceutical Market Revenue, by Geography ($bn), 2017-2027

Companies Listed

  • Abbott Medical Optics
  • Aché Laboratórios Farmacêuticos
  • Actavis
  • Adams Respiratory Therapeutics
  • Akorn
  • Alcon
  • Allergan
  • Alliance Boots
  • Almirall
  • Amerisource Bergen
  • ANVISA
  • Apotex
  • Arena Pharmaceuticals
  • Aspen Pharmacare
  • Astellas Pharma
  • AstraZeneca
  • Aurobindo
  • B.F. Ascher & Company
  • Bausch & Lomb
  • Bayer
  • Boehringer Ingelheim
  • Boots
  • Bristol-Myers Squibb
  • Cardinal Health
  • Celesio
  • China Resources Sanjiu Pharmaceutical
  • Ciba
  • Cilag
  • Cipla
  • Costco
  • CSPC (China Shijiazhuang Pharmaceutical Group)
  • CVS
  • Daiichi Sankyo
  • Dalkhimpharm
  • Dollar General
  • Dr. Reddy's Laboratories
  • Eisai
  • Eli Lilly
  • EMS
  • Eurofarma
  • Fosun Pharma
  • Galderma
  • Genomma Lab
  • GSK
  • Guangzhou Pharmaceutical
  • Harbin Pharmaceutical Group
  • Heritage/Insight
  • Hisamitsu
  • Hypermacas
  • Im Co., Ltd.
  • Insight
  • Ipca Laboratories
  • JB Chemicals
  • Johnson & Johnson
  • Kangmei Pharmaceutical
  • Kowa
  • Kroger
  • Lion
  • LOréal
  • Lupin Limited
  • Mankind Pharma
  • McKesson
  • Mead Johnson
  • Menarini
  • Merck
  • Mylan
  • North China Pharmaceutical
  • Novartis
  • Nycomed
  • Omega Pharma
  • Otsuka
  • Paras Pharmaceuticals
  • Perrigo
  • Pfizer
  • Pharmstandard
  • Phoenix
  • Prestige Brands
  • Procter & Gamble
  • Purdue Pharma
  • Ranbaxy
  • Ratiopharm
  • Reckitt Benckiser
  • Roche
  • Rohto
  • Roxane Labs
  • Sam's Club
  • Sandoz
  • Sanofi
  • Sato
  • Sergeant
  • Shanghai Pharmaceuticals
  • Shionogi
  • Sinopharm
  • SkyePharma
  • Somaxon Pharmaceuticals
  • Sotex
  • SSL International
  • Stada
  • Sun Pharma
  • Taisho
  • Takeda
  • Teva
  • Torrent Pharmaceuticals
  • Typharm
  • UCB Pharma
  • União Química
  • Valeant
  • Velcera
  • Veropharm
  • Vivus

Organizations Mentioned in the Report

  • Association of the European Self-Medication Industry (AESGP)
  • National Pharmaceutical Pricing Authority (NPPA)
  • The Brazilian Health Surveillance Agency
  • The European Medicines Agency (EMA)
  • The Food and Drug Administration (FDA)
  • The General Directorate of Pharmaceuticals and Pharmacy (IEGM) (Turkey)
  • The Medicines and Healthcare products Regulatory Agency (MHRA)
  • The Ministry of Health, Labour and Welfare (MHLW)
  • The Pharmaceutical and Medical Devices Agency (PMDA)
Back to Top